The express service provider trans-o-flex plans to go public

The trans-o-flex Express GmbH, which is expected to be converted into a partnership limited by shares under the name trans-o-flex Express GmbH & Co. KGaA (the “Company”), is preparing for an initial public offering (“IPO”) and the listing of its shares on the regulated market of the Frankfurt Stock Exchange (Prime Standard). The IPO is planned for the fourth quarter of this year.

(Weinheim) The trans-o-flex Express GmbH plans to complete the offering in Q4 2021, depending on market conditions. The offering is expected to include newly issued bearer shares without par value from a capital increase against cash contributions, existing bearer shares without par value from current shareholders, as well as bearer shares without par value in connection with possible over-allotments (the “Offering”), which are covered by an over-allotment option (Greenshoe) from existing shareholders. The Offering includes a public offering of shares in Germany as well as private placements of shares in certain jurisdictions outside Germany.

GDP-compliant logistics for sensitive pharmaceuticals in Germany

trans-o-flex is the leading full-service specialized logistics provider for customers in the pharmaceutical and healthcare sectors and a leading premium provider of logistics solutions for other high-quality goods in Germany. The company operates two nationwide, actively temperature-controlled express logistics networks, “trans-o-flex ThermoMed” (2–8°C) and “trans-o-flex Express” (15–25°C), both of which fully comply with the standards of the EU GDP Directive (Good Distribution Practice). With its highly flexible networks based on an asset-light approach, trans-o-flex offers secure delivery of medications, sensitive devices for life sciences companies, beauty products, and other high-quality goods (e.g., household and consumer electronics) within 24 hours in Germany and Austria.

The trans-o-flex announcement in detail

Photo: © trans-o-flex